Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Return on Equity (2022 - 2025)

Historic Return on Equity for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to 0.06%.

  • Rxo's Return on Equity rose 1100.0% to 0.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.06%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.06% for FY2025, which is 2000.0% up from last year.
  • As of Q4 2025, Rxo's Return on Equity stood at 0.06%, which was up 1100.0% from 0.05% recorded in Q3 2025.
  • In the past 5 years, Rxo's Return on Equity ranged from a high of 0.11% in Q4 2022 and a low of 0.24% during Q3 2024
  • Its 4-year average for Return on Equity is 0.06%, with a median of 0.04% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -2300bps in 2024, then surged by 1900bps in 2025.
  • Over the past 4 years, Rxo's Return on Equity (Quarter) stood at 0.11% in 2022, then plummeted by -94bps to 0.01% in 2023, then plummeted by -2730bps to 0.18% in 2024, then skyrocketed by 64bps to 0.06% in 2025.
  • Its Return on Equity was 0.06% in Q4 2025, compared to 0.05% in Q3 2025 and 0.19% in Q2 2025.